Uriach acquires the HuPaVir brand to complete its immune system product portfolio
The Catalan company Uriach closes with NTD Labs the acquisition of its brand HuPaVir to complete its portfolio of products on the immune system. The new treatment is incorporated into the Uriach Medical line to integrate the category of products aimed at preventing the spread of HPV (Human Papilloma Virus). Thus,...